ClinicalTrials.Veeva

Menu

Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan

GlaxoSmithKline (GSK) logo

GlaxoSmithKline (GSK)

Status

Completed

Conditions

Intussusception

Treatments

Other: Data collection

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

This study aims to analyse baseline data on IS in order to monitor the possibility of increased risk of IS in children aged <12 months after introduction of the Rotarix vaccination in Japan.

Enrollment

54 patients

Sex

All

Ages

Under 12 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A male or female infant aged < 12 months at the time of IS diagnosis and affiliated to the JMDC-MDB database.
  • An IS case should be identified as per the ICD-10 diagnostic code-K56.1 (any-field listed), examination codes, and procedural codes.

Exclusion criteria

Not applicable

Trial design

54 participants in 1 patient group

Case Group
Description:
Children aged \< 12 months presenting with IS and covered by the Japan Medical Data Centre Company Limited (JMDC), Tokyo referred to as the JMDC Medical Data Bank (JMDC-MDB).
Treatment:
Other: Data collection

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems